AOL Web Search

  1. About 43 search results
  1. Web results:
  2. CDC Recommends Novavax for Teens: What to Know About the ...

    www.cnet.com/health/medical/cdc-recommends...

    Novavax is the first protein-based vaccine for COVID-19 available in the US, which is a more traditional vaccine type. Bringing one more on board gives people who aren't vaccinated yet another option.

  3. The Novavax vaccine against COVID-19: What you need to know

    www.who.int/news-room/feature-stories/detail/the...

    The efficacy of Novavax(NVX-CoV2373) in adolescents 12 to 17 years of age was evaluated in an interim analysis of the paediatric expansion portion of the ongoing phase 3 study in United States. The vaccine effectiveness reached 80% for this population.

  4. Nuvaxovid (Novavax) | Australian Government Department of ...

    www.health.gov.au/.../approved-vaccines/novavax

    Novavax is approved and available for use as a booster in people aged 18 years and over. The TGA provisionally approved Novavax for use as a primary course in Australia on 20 January 2022. The TGA provisionally approved Novavax for use as a booster on 9 July 2022. Dose schedule Primary course

  5. COVID-19 vaccines: Getting Novavax | Ministry of Health NZ

    www.health.govt.nz/covid-19-novel-coronavirus/...

    It is also available as a booster at least 6 months after completing the primary course for any of the COVID-19 vaccines available in New Zealand. Novavax is the first protein-based COVID-19 vaccine to be approved for use in New Zealand and helps prevent you from getting infected and having COVID-19 symptoms, or severe illness.

  6. Detroit Health Department providing Novavax COVID-19 vaccine ...

    www.cbsnews.com/detroit/news/detroit-health...

    The Detroit Health Department is now providing the Novavax two-dose COVID-19 vaccine and the new bivalent booster doses to residents ages 12 and up. ... Vaccinations and boosters are available at ...

  7. Novavax stock ends 6% higher, snaps eight-day losing streak ...

    seekingalpha.com/news/3886579-novavax-stock-ends...

    Shares of U.S. vaccine maker Novavax (NVAX) on Tuesday closed about 6% higher, ending an eight-session losing streak which included a ~27% drop in the last three days